These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15808801)

  • 21. Thrombocytopenia during levetiracetam therapy.
    Meschede A; Runge U; Sabolek M
    Epilepsy Res; 2008 Jul; 80(1):91-2. PubMed ID: 18424076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypersomnia in an epilepsy patient treated with levetiracetam.
    Khatami R; Siegel AM; Bassetti CL
    Epilepsia; 2005 Apr; 46(4):588-9. PubMed ID: 15816957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impending status epilepticus and anxiety in a pregnant woman treated with levetiracetam.
    Novy J; Hubschmid M; Michel P; Rossetti AO
    Epilepsy Behav; 2008 Oct; 13(3):564-6. PubMed ID: 18589001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
    Garlantézec R; Monfort C; Rouget F; Cordier S
    Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
    Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of levetiracetam on cognition: a non-interventional surveillance study.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2008 Nov; 13(4):642-9. PubMed ID: 18707022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyponatremia associated with repeated use of levetiracetam.
    Nasrallah K; Silver B
    Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
    Schaefer C; Hannemann D; Meister R
    Reprod Toxicol; 2005; 20(3):331-43. PubMed ID: 15978773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. North American antiepileptic drug pregnancy registry.
    Holmes LB; Wyszynski DF
    Epilepsia; 2004 Nov; 45(11):1465. PubMed ID: 15509251
    [No Abstract]   [Full Text] [Related]  

  • 32. Maternal contamination with dichlorodiphenyltrichloroethane and reproductive outcomes in an Australian population.
    Khanjani N; Sim MR
    Environ Res; 2006 Jul; 101(3):373-9. PubMed ID: 16360142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Encephalopathy induced by levetiracetam added to valproate.
    Bauer J
    Acta Neurol Scand; 2008 May; 117(5):374-6. PubMed ID: 18081909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
    Wikner BN; Stiller CO; Bergman U; Asker C; Källén B
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1203-10. PubMed ID: 17894421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suicidal ideation in epilepsy and levetiracetam therapy.
    Mula M; Sander JW
    Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.
    Wojda E; Wlaz A; Patsalos PN; Luszczki JJ
    Epilepsy Res; 2009 Oct; 86(2-3):163-74. PubMed ID: 19596559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.
    Szucs A; Clemens Z; Jakus R; Rásonyi G; Fabó D; Holló A; Barcs G; Kelemen A; Janszky J
    Epilepsia; 2008 Jul; 49(7):1174-9. PubMed ID: 18479387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists.
    Meijer WM; de Walle HE; Kerstjens-Frederikse WS; de Jong-van den Berg LT
    Reprod Toxicol; 2005; 20(2):203-7. PubMed ID: 15907654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levetiracetam Pregnancy Registry: Final results and a review of the impact of registry methodology and definitions on the prevalence of major congenital malformations.
    Scheuerle AE; Holmes LB; Albano JD; Badalamenti V; Battino D; Covington D; Harden C; Miller D; Montouris GD; Pantaleoni C; Thorp J; Tofighy A; Tomson T; Golembesky AK
    Birth Defects Res; 2019 Aug; 111(13):872-887. PubMed ID: 31124321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.